Cancer Research Meeting Calendar  Metabolism and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueki, T.
Right arrow Articles by Goggins, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueki, T.
Right arrow Articles by Goggins, M.
[Cancer Research 61, 8540-8546, December 1, 2001]
© 2001 American Association for Cancer Research


Molecular Biology and Genetics

Identification and Characterization of Differentially Methylated CpG Islands in Pancreatic Carcinoma1

Takashi Ueki, Minoru Toyota, Hal Skinner, Kimberly M. Walter, Charles J. Yeo, Jean-Pierre J. Issa, Ralph H. Hruban and Michael Goggins2

Departments of Pathology [T. U., K. M. W., R. H. H., M. G.], Oncology [M. T., R. H. H., M. G.], Surgery [C. J. Y.], Epidemiology [H. S.], and Medicine [M. G.], Johns Hopkins School of Medicine and the Johns Hopkins School of Public Health, Baltimore, Maryland 21205, and the Department of Leukemia of University of Texas at MD Anderson Cancer Center, Houston, Texas 77030 [J-P. J. I.]

To identify CpG islands differentially methylated in pancreatic adenocarcinoma, we used methylated CpG island amplification (MCA) coupled with representational difference analysis. Of 42 CpG islands identified by MCA/representational difference analysis, 7 CpG islands [methylated in carcinoma of the pancreas (MICP)] were differentially methylated in a panel of eight pancreatic cancer cell lines compared with normal pancreas. In a larger panel of 75 pancreatic adenocarcinomas, these 7 MICPs (ppENK, Cyclin G, ZBP, MICP25, 27, 36, and 38) were methylated in 93, 3, 9, 15, 48, 19, and 41% of cancers, respectively, by methylation-specific PCR but not in any of 15 normal pancreata. In pancreatic cancer cell lines, methylation of ppENK, a gene with known growth suppressive properties, was associated with transcriptional silencing that was reversible with 5-aza-2'-deoxycytidine treatment. Relationships between the methylation patterns of pancreatic adenocarcinomas and their clinicopathological features were also determined. Larger pancreatic cancers and those from older patients (P = 0.017) harbored more methylated loci than smaller tumors and those from younger patients (P = 0.017). ppENK, MICP25, and 27 were variably methylated in normal gastric, duodenal, and colonic mucosae.

These data indicate that aberrant methylation of ppENK and its transcriptional repression is a common event in pancreatic carcinogenesis.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Brune, S.-M. Hong, A. Li, S. Yachida, T. Abe, M. Griffith, D. Yang, N. Omura, J. Eshleman, M. Canto, et al.
Genetic and Epigenetic Alterations of Familial Pancreatic Cancers
Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3536 - 3542.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. C. Larsson, N. Hakansson, E. Giovannucci, and A. Wolk
Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men.
J Natl Cancer Inst, March 15, 2006; 98(6): 407 - 413.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Matsubayashi, M. Canto, N. Sato, A. Klein, T. Abe, K. Yamashita, C. J. Yeo, A. Kalloo, R. Hruban, and M. Goggins
DNA Methylation Alterations in the Pancreatic Juice of Patients with Suspected Pancreatic Disease
Cancer Res., January 15, 2006; 66(2): 1208 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Matsubayashi, N. Sato, K. Brune, A. L. Blackford, R. H. Hruban, M. Canto, C. J. Yeo, and M. Goggins
Age- and Disease-Related Methylation of Multiple Genes in Nonneoplastic Duodenum and in Duodenal Juice
Clin. Cancer Res., January 15, 2005; 11(2): 573 - 583.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
H. G. Skinner, D. S. Michaud, E. L. Giovannucci, E. B. Rimm, M. J. Stampfer, W. C. Willett, G. A. Colditz, and C. S. Fuchs
A Prospective Study of Folate Intake and the Risk of Pancreatic Cancer in Men and Women
Am. J. Epidemiol., August 1, 2004; 160(3): 248 - 258.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Obata, M. Toyota, A. Satoh, Y. Sasaki, K. Ogi, K. Akino, H. Suzuki, M. Murai, T. Kikuchi, H. Mita, et al.
Identification of HRK as a Target of Epigenetic Inactivation in Colorectal and Gastric Cancer
Clin. Cancer Res., December 15, 2003; 9(17): 6410 - 6418.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Lee, H. J. Lee, J.-H. Kim, H.-S. Lee, J. J. Jang, and G. H. Kang
Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis
Am. J. Pathol., October 1, 2003; 163(4): 1371 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. A. Palmisano, K. P. Crume, M. J. Grimes, S. A. Winters, M. Toyota, M. Esteller, N. Joste, S. B. Baylin, and S. A. Belinsky
Aberrant Promoter Methylation of the Transcription Factor Genes PAX5 {alpha} and {beta} in Human Cancers
Cancer Res., August 1, 2003; 63(15): 4620 - 4625.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Sato, A. Maitra, N. Fukushima, N. T. van Heek, H. Matsubayashi, C. A. Iacobuzio-Donahue, C. Rosty, and M. Goggins
Frequent Hypomethylation of Multiple Genes Overexpressed in Pancreatic Ductal Adenocarcinoma
Cancer Res., July 15, 2003; 63(14): 4158 - 4166.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Sato, N. Fukushima, A. Maitra, H. Matsubayashi, C. J. Yeo, J. L. Cameron, R. H. Hruban, and M. Goggins
Discovery of Novel Targets for Aberrant Methylation in Pancreatic Carcinoma Using High-Throughput Microarrays
Cancer Res., July 1, 2003; 63(13): 3735 - 3742.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Matsubayashi, N. Sato, N. Fukushima, C. J. Yeo, K. M. Walter, K. Brune, F. Sahin, R. H. Hruban, and M. Goggins
Methylation of Cyclin D2 Is Observed Frequently in Pancreatic Cancer but Is Also an Age-related Phenomenon in Gastrointestinal Tissues
Clin. Cancer Res., April 1, 2003; 9(4): 1446 - 1452.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. G. House, M. Guo, C. Iacobuzio-Donahue, and J. G. Herman
Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas
Carcinogenesis, February 1, 2003; 24(2): 193 - 198.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Fukushima, N. Sato, T. Ueki, C. Rosty, K. M. Walter, R. E. Wilentz, C. J. Yeo, R. H. Hruban, and M. Goggins
Aberrant Methylation of Preproenkephalin and p16 Genes in Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal Adenocarcinoma
Am. J. Pathol., May 1, 2002; 160(5): 1573 - 1581.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.